
Elinzanetant Data to Feature Prominently at Congress of the European Society of Gynecology: Bayer Update
Bayer will present findings from its phase 3 clinical development program for elinzanetant at the 16th Congress of the European Society of Gynecology (ESG) in Riga, Latvia, being held April 1-5, 2025, according to a company announcement this morning. The …